v3 Template
A

Allucent

Pharmaceuticals / Biotechnology ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$25.5M
Funding Rounds
1
Last Funding
2024-05-15

About Allucent

Allucent is a global pharmaceutical contract research organization (CRO) focused on supporting small and mid-sized biotech companies in drug development. With over 30 years of experience, they provide innovative strategies and robust solutions to navigate the complexities of clinical research, from therapeutic innovation to regulatory approval, with a mission to bring new therapies to light.

Products & Services

Clinical Development:Services include study start-up, site intelligence, patient recruitment and retention, decentralized clinical trials, data management, biostatistics, statistical programming, and medical monitoring.
Clinical Pharmacology:Offers drug development strategy, regulatory support, modeling and simulation, end-to-end pharmacokinetics, and embedded pharmacologist consulting.
Regulatory Strategy:Provides support in CMC and preclinical, clinical strategy, biostatistical consulting, regulatory submissions, and GxP consulting.
Drug Safety & Pharmacovigilance:Includes clinical trial safety and post-marketing pharmacovigilance services.
Government & Public Health Services:Clinical research services tailored for government and public health needs.

Specialties

Oncology & Hematology Infectious Disease & Vaccine Neuroscience Immunology and Inflammation Cardiometabolic Disease Allergy & Asthma Cell & Gene Therapy Rare Diseases Pediatrics Clinical Pharmacology Regulatory Strategy Drug Safety & Pharmacovigilance Decentralized Clinical Trials

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 25500000
MR: -
FA: $25.5 million
FAN: 25500000
D: 2024-05-15
FD: 2024-05-15
1 investors
Grant Latest
2024-05-15
$25.5M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Paula Brown Stafford

CEO

H

Howard Brand

Chief Financial Officer

S

Steffany Cox

Chief Marketing Officer

L

Leslie DeVos

President, Regulatory and Drug Development Consulting

K

Katy Moore

President, Clinical Pharmacology Modeling and Simulation

T

Teresa Nunes

Chief Medical Officer

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Allucent Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals / Biotechnology
Company Size
~150 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro